Goals
- A productive dialogue with stakeholders from community, regulators, and industry, to better the mutual understanding of risks and benefits involved with broadening access to HCV experimental drugs.
- Broaden access to experimental HCV therapies by promoting regulatory changes and company commitment, and through increasing provider and community awareness.
- Promoting the creation of an international network of HIV/HCV co-infection activists.
